AMRX PDUFA decision: a positive outcome, +7.9%

On December 8, 2023, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +7.9% in the window around the event. It had already run +13.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.